Redwood Scientific Technologies, Inc. (RSCI)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
Nov 5, 2025, 4:00 PM EST
RSCI Market Cap
RSCI has a market cap or net worth of $2.27 million as of November 6, 2025. Its market cap has decreased by -19.08% in one year.
Market Cap
2.27M
Enterprise Value
n/a
Revenue
259.71K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since October 22, 2009, RSCI's market cap has decreased from 1.71B to 2.27M, a decrease of -99.87%. That is a compound annual growth rate of -33.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2025 | 2.27M | -89.29% |
| Dec 31, 2024 | 21.23M | -6.40% |
| Dec 27, 2023 | 22.68M | 2,024.85% |
| Dec 30, 2022 | 1.07M | -87.98% |
| Dec 29, 2020 | 8.88M | 399.00% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 22, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.18M |
| Elite Pharmaceuticals | 654.92M |
| Glass House Brands | 582.61M |
| Northwest Biotherapeutics | 373.25M |
| Nika Pharmaceuticals | 311.89M |
| CytoDyn | 311.61M |
| Silence Therapeutics | 307.49M |
| American Oncology Network | 307.04M |